Okubo Y - Search Results

1

Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.

Faustman DL, Wang L, Okubo Y, Burger D, Ban L, Man G, Zheng H, Schoenfeld D, Pompei R, Avruch J, Nathan DM. Faustman DL, et al. Among authors: okubo y. PLoS One. 2012;7(8):e41756. doi: 10.1371/journal.pone.0041756. Epub 2012 Aug 8. PLoS One. 2012. PMID: 22905105 Free PMC article. Clinical Trial.

2

Novel automated blood separations validate whole cell biomarkers.

Burger DE, Wang L, Ban L, Okubo Y, Kühtreiber WM, Leichliter AK, Faustman DL. Burger DE, et al. Among authors: okubo y. PLoS One. 2011;6(7):e22430. doi: 10.1371/journal.pone.0022430. Epub 2011 Jul 22. PLoS One. 2011. PMID: 21799852 Free PMC article.

3

Homogeneous expansion of human T-regulatory cells via tumor necrosis factor receptor 2.

Okubo Y, Mera T, Wang L, Faustman DL. Okubo Y, et al. Sci Rep. 2013 Nov 6;3:3153. doi: 10.1038/srep03153. Sci Rep. 2013. PMID: 24193319 Free PMC article.

4

Strategic internal covalent cross-linking of TNF produces a stable TNF trimer with improved TNFR2 signaling.

Ban L, Kuhtreiber W, Butterworth J, Okubo Y, Vanamee ÉS, Faustman DL. Ban L, et al. Among authors: okubo y. Mol Cell Ther. 2015 Aug 12;3:7. doi: 10.1186/s40591-015-0044-4. eCollection 2015. Mol Cell Ther. 2015. PMID: 26266038 Free PMC article.

5

Treg activation defect in type 1 diabetes: correction with TNFR2 agonism.

Okubo Y, Torrey H, Butterworth J, Zheng H, Faustman DL. Okubo Y, et al. Clin Transl Immunology. 2016 Jan 8;5(1):e56. doi: 10.1038/cti.2015.43. eCollection 2016 Jan. Clin Transl Immunology. 2016. PMID: 26900470 Free PMC article.

6

A novel TNFR2 agonist antibody expands highly potent regulatory T cells.

Torrey H, Kühtreiber WM, Okubo Y, Tran L, Case K, Zheng H, Vanamee E, Faustman DL. Torrey H, et al. Among authors: okubo y. Sci Signal. 2020 Dec 8;13(661):eaba9600. doi: 10.1126/scisignal.aba9600. Sci Signal. 2020. PMID: 33293464

7

Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs.

Torrey H, Butterworth J, Mera T, Okubo Y, Wang L, Baum D, Defusco A, Plager S, Warden S, Huang D, Vanamee E, Foster R, Faustman DL. Torrey H, et al. Among authors: okubo y. Sci Signal. 2017 Jan 17;10(462):eaaf8608. doi: 10.1126/scisignal.aaf8608. Sci Signal. 2017. PMID: 28096513

8

Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen.

Dieguez-Acuña F, Kodama S, Okubo Y, Paz AC, Gygi SP, Faustman DL. Dieguez-Acuña F, et al. Among authors: okubo y. Int J Biochem Cell Biol. 2010 Oct;42(10):1651-60. doi: 10.1016/j.biocel.2009.12.001. Epub 2009 Dec 18. Int J Biochem Cell Biol. 2010. PMID: 20005973 Free PMC article.

9

Successful Total Callosotomy in a Patient with Lennox-Gastaut Syndrome and Cardio-Facio-Cutaneous Syndrome.

Kawashima A, Nakamura H, Kodama K, Okubo Y, Endo W, Inui T, Togashi N, Uneoka S, Shibuya M, Oikawa Y, Katata Y, Numata-Uematsu Y, Uematsu M, Kawame H, Osawa SI, Oba D, Niihori T, Aoki Y, Haginoya K. Kawashima A, et al. Among authors: okubo y. Tohoku J Exp Med. 2024 Dec 19. doi: 10.1620/tjem.2024.J146. Online ahead of print. Tohoku J Exp Med. 2024. PMID: 39694493 Free article. No abstract available.

10

Virtual reality obstacle avoidance training can be enhanced by physical feedback via perturbations: A proof-of-concept study.

Okubo Y, He Y, Brodie MA, Hicks C, van Schooten K, Lovell NH, Anstey KJ, Lord SR, Kim J. Okubo Y, et al. Appl Ergon. 2024 Dec 16;125:104442. doi: 10.1016/j.apergo.2024.104442. Online ahead of print. Appl Ergon. 2024. PMID: 39689670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,406 results

Search Page

Filters